Groups information

Group name

Individualized information

Groups definition

patients were included after the introduction of continence prediction tool (CPRED) and received individualized in_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x0002_formation about the risk of UI after RARP (cohort individualized information)

Groups remarks

The institutional review board of the the Netherlands Cancer Institute (NCI) approved the study

Baseline information

Age

66.6

Age p-value

0.57

Age remark

mean in years

BMI

26.4

BMI remark

mean

PSA

12.28

PSA p-value

0.599

PSA remark

PSA (mean in ng/L)

Prostate volume

44.8

Prostate volume p-value

0.773

Prostate volume remark

Prostate volume (mean in cc)

American Society of Aneshesiologists (ASA) physical status classification
Charlson comorbidity index (CCI)
Risk classification

Institutes for Systems Genetics, West China Hospital
     Copyright @ 2023 ISG. All Rights Reserved.